Delivery Order SPE2DB20D1100-SPE2DB24FC1V8
Award Date
6/10/24
Potential Completion Date
6/11/24
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,001.17, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a pharmaceutical product, with an ultimate completion date of April 23, 2024. This is a firm fixed-price delivery order contract, awarded without any set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite...
This federal contract award is a delivery order valued at $1,093.56 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a specialty medication, with an ultimate completion date of December 9, 2024. Amerisourcebergen, a for-profit organization, holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the...
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) for $999,999,999. The contract provides a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The specific award is for 4,558,478,916 units of...
This federal contract award is a delivery order valued at $2,426.43 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a medical product, with a period of performance through October 25, 2024. The award was made by the Defense Logistics Agency (DLA), a defense agency, and is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
The Defense Logistics Agency awarded a $1,151.91 firm fixed price delivery order to AmerisourceBergen Drug Corp, a for-profit organization, for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML pharmaceutical products. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract held by AmerisourceBergen Drug Corp, which serves as the primary vehicle for the company to provide pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the...
This is a delivery order award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,554.12 firm-fixed-price contract is for the supply of GVOKE HYPOPEN 1-PK 1 MG/0.2 ML 0.2ML, a medical product. The contract has an ultimate completion date of February 11, 2025. This award is under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award is for the delivery of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,567.55, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation, and is a firm fixed price delivery order. The award is not associated with any set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,065.93 firm fixed-price contract is for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a medical product, with a completion date of December 30, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,200.94, is a delivery order for GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML and has an ultimate completion date of April 4, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., and the parent company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The order is for the supply of GVOKE HYPOPEN 2PK 0.5MG/0.1 ML 0.1ML, a pharmaceutical product, with a ceiling value of $8,338.30 and a performance period ending on May 21, 2024. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the federal government, with a significant...